“…The yeast UPF1 gene and its protein product have been the most extensively investigated factor in the NMD pathway (Altamura et al+, 1992;Koonin, 1992;Leeds et al+, 1992;Atkin et al+, 1995Atkin et al+, , 1997Czaplinski et al+, 1995Czaplinski et al+, , 1999Cui et al+, 1996;Weng et al+, 1996aWeng et al+, , 1996bWeng et al+, , 1998)+ The Upf1p contains a cysteine-and histidine-rich region near its amino terminus and all the motifs of the superfamily group I helicases+ The yeast Upf1p has been purified and demonstrated to have RNA-binding activity, RNA-dependent ATPase activity, and RNA helicase activity (Czaplinski et al+, 1995, Weng et al+, 1996a, 1996b)+ Disruption of the UPF1 gene results in stabilization of nonsense-containing mRNAs and suppression of certain nonsense alleles (Leeds et al+, 1991;Cui et al+, 1995;Czaplinski et al+, 1995;Weng et al+, 1996aWeng et al+, , 1996b)+ A set of mutations was isolated in the UPF1 gene that separated its mRNA decay function from its activity in modulating translation termination at a nonsense codon (Weng et al+, 1996a(Weng et al+, , 1996b)+ Consistent with the view that the Upf1p is involved in modulating translation termination, recent results have shown that it interacts with the translation termination release factors eRF1 and eRF3 (Czaplinski et al+, 1998(Czaplinski et al+, , 1999)+ These data suggest that the NMD and translation termination pathways are linked (reviewed in Czaplinski et al+, 1998Czaplinski et al+, , 1999)+ Based on these observations, a "surveillance complex" consisting of at least Upf1p, Upf2p, Upf3p, and the release factors has been suggested to modulate translation termination and NMD (Czaplinski et al+, 1998(Czaplinski et al+, , 1999)+ Homologs of the Upf1p have been identified in humans cells (the HUPF1/RENT gene; Perlick et al+, 1996, Applequist et al+, 1997 and in C. elegans (Page et al+, 1999;Jacobson & Peltz, 1996; WORMPEP: Y48G8A 3304+a)+ It is evident that the Upf1p plays a conserved role in NMD...…”